Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed Mostafa

Showing results (391-400 of 463) with videos related to

Pageof 47
Sort By:
Antibiotics (Basel, Switzerland)|June 2, 2021
Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 TherapeuticsHani A Alhadrami, Ahmed M Sayed, Hossam M Hassan, et al.
Microorganisms|November 25, 2023
Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229EYassmin Moatasim, Omnia Kutkat, Ahmed M Osman, et al.
Virus Evolution|December 21, 2020
Genetic incompatibilities and reduced transmission in chickens may limit the evolution of reassortants between H9N2 and panzootic H5N8 clade 2.3.4.4 avian influenza virus showing high virulence for mammalsAhmed Mostafa, Claudia Blaurock, David Scheibner, et al.
RSC Advances|May 2, 2022
β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, <i>in silico</i>, <i>in vitro</i>, and SAR studies for lead optimizationMohammed I A Hamed, Khaled M Darwish, Raya Soltane, et al.
Vaccines|May 31, 2019
Bacterial Outer Membrane Vesicles (OMVs)-based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoVMahmoud M Shehata, Ahmed Mostafa, Lisa Teubner, et al.
Breast Care (Basel, Switzerland)|March 15, 2021
Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among ArabsKausar Suleman, Ali Hassan Mushtaq, Emaan Haque, et al.
Microorganisms|June 26, 2026
Phenotypic Fosfomycin Susceptibility and Detection of Plasmid-Mediated Resistance Genes in Clinical Uropathogenic <i>Escherichia coli</i> IsolatesEman E Hegazy, Esraa A Mohamed, Shaimaa S E Marey, et al.
Pharmaceutics|March 3, 2021
Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking StudiesMohammed W Al-Rabia, Nabil A Alhakamy, Osama A A Ahmed, et al.
Emerging Infectious Diseases|December 17, 2011
Continuing threat of influenza (H5N1) virus circulation in EgyptGhazi Kayali, Rabeh El-Shesheny, Mohamed A Kutkat, et al.
Cureus|October 8, 2025
Ultrasonographic Predictors of Difficult Laparoscopic CholecystectomyIbrahim Asim, Ahmed Taymour Algahiny, Omar HeshamEldin Abouelella, et al.
Pageof 47

Showing results (391-400 of 463) with videos related to

Sort By:
Pageof 47
Antibiotics (Basel, Switzerland)|June 2, 2021
Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 TherapeuticsHani A Alhadrami, Ahmed M Sayed, Hossam M Hassan, et al.
Microorganisms|November 25, 2023
Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229EYassmin Moatasim, Omnia Kutkat, Ahmed M Osman, et al.
Virus Evolution|December 21, 2020
Genetic incompatibilities and reduced transmission in chickens may limit the evolution of reassortants between H9N2 and panzootic H5N8 clade 2.3.4.4 avian influenza virus showing high virulence for mammalsAhmed Mostafa, Claudia Blaurock, David Scheibner, et al.
RSC Advances|May 2, 2022
β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, <i>in silico</i>, <i>in vitro</i>, and SAR studies for lead optimizationMohammed I A Hamed, Khaled M Darwish, Raya Soltane, et al.
Vaccines|May 31, 2019
Bacterial Outer Membrane Vesicles (OMVs)-based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoVMahmoud M Shehata, Ahmed Mostafa, Lisa Teubner, et al.
Breast Care (Basel, Switzerland)|March 15, 2021
Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among ArabsKausar Suleman, Ali Hassan Mushtaq, Emaan Haque, et al.
Microorganisms|June 26, 2026
Phenotypic Fosfomycin Susceptibility and Detection of Plasmid-Mediated Resistance Genes in Clinical Uropathogenic <i>Escherichia coli</i> IsolatesEman E Hegazy, Esraa A Mohamed, Shaimaa S E Marey, et al.
Pharmaceutics|March 3, 2021
Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking StudiesMohammed W Al-Rabia, Nabil A Alhakamy, Osama A A Ahmed, et al.
Emerging Infectious Diseases|December 17, 2011
Continuing threat of influenza (H5N1) virus circulation in EgyptGhazi Kayali, Rabeh El-Shesheny, Mohamed A Kutkat, et al.
Cureus|October 8, 2025
Ultrasonographic Predictors of Difficult Laparoscopic CholecystectomyIbrahim Asim, Ahmed Taymour Algahiny, Omar HeshamEldin Abouelella, et al.
Pageof 47